Bristol-Myers Squibb Company
6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as APJ agonists
Last updated:
Abstract:
The present invention provides compounds of Formula (I): ##STR00001## wherein all variables are as defined in the specification, and compositions comprising any of such novel compounds. These compounds are APJ agonists which may be used as medicaments.
Status:
Grant
Type:
Utility
Filling date:
6 Sep 2018
Issue date:
17 Mar 2020